AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

  1. Toshihiro Miyamoto,
  2. Irving L. Weissman, and
  3. Koichi Akashi*
  1. Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305
  1. Contributed by Irving L. Weissman

Abstract

Leukemia-specific AML1/ETO transcripts are detectable in most patients with t(8;21) acute myelogenous leukemia (AML) in long-term remission. To understand the inconsistency between the clinical cure and the presence of “residual disease” at a molecular level, we separated and identified the cells expressing AML1/ETO by phenotype and function. Here we demonstrate that AML1/ETO transcripts are present in a fraction of stem cells, monocytes, and B cells in remission marrow, and in a fraction of B cells in leukemic marrow, but not in T cells. AML1/ETO transcripts also were demonstrated in a fraction of colony-forming cells of erythroid, granulocyte-macrophage, and/or megakaryocyte lineages in both leukemic and remission marrow. These data strongly suggest that the acquisition of the t(8;21) occurs at the level of stem cells capable of differentiating into B cells as well as all myeloid lineages, and that a fraction of the AML1/ETO-expressing stem cells undergo additional oncogenic event(s) that ultimately leads to transformation into AML.

Footnotes

  • * To whom reprint requests should be sent at present address: Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, Sm 770B, 44 Binney Street, Boston, MA 02115. E-mail: Koichi_akashi{at}dfci.harvard.edu.

  • Abbreviations:
    AML,
    acute myelogenous leukemia;
    HSC,
    hematopoietic stem cells;
    MBT,
    mobilized blood transplantation;
    RT-PCR,
    reverse transcriptase–PCR;
    BFU-E,
    burst-forming unit-erythroid;
    CFU-Meg,
    colony-forming unit-megakaryocytes;
    CFU-GM,
    colony-forming unit granulocyte/macrophages;
    BM,
    bone marrow;
    Lin,
    lineage;
    CLP,
    common lymphoid progenitors;
    MPO,
    myeloperoxidase;
    EBV,
    Epstein–Barr virus
« Previous | Next Article »Table of Contents